Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name AK104
Trade Name
Synonyms AK-104|AK 104
Drug Descriptions

AK104 is a monoclonal antibody against CD274 (PD-L1) that inhibits binding to the PDCD1 (PD1) receptor, potentially resulting in enhanced anti-tumor immune response (PMID: 29932513).

DrugClasses Immune Checkpoint Inhibitor 135 PD-L1/PD-1 antibody 79
CAS Registry Number 2233593-44-5
NCIT ID C153379


  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"


  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
AK104 AK104 0 2
AK104 + Anlotinib AK104 Anlotinib 0 0
AK104 + Capecitabine + Oxaliplatin AK104 Capecitabine Oxaliplatin 0 0
AK104 + Lenvatinib AK104 Lenvatinib 0 0

Additional content available in CKB BOOST